A
DGX icon

Allianz’s Quest Diagnostics DGX Stock Holding History

Allianz’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35
Closed -$5.92K – 407
2025
Q1 		$5.92K Hold
35
– – ﹤0.01% 410
2024
Q4 		$5.28K Sell
35
-140
-80% -$21.8K ﹤0.01% 423
2024
Q3 		$27.2K Hold
175
– – ﹤0.01% 360
2024
Q2 		$24K Sell
175
-85
-33% -$11.6K ﹤0.01% 418
2024
Q1 		$34.6K Buy
+260
New +$33.7K ﹤0.01% 414

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz's DGX Position: Q2 2025 in Review

Allianz sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 35 shares — an estimated $5.92K sold.

Allianz first reported a position in DGX in Q1 2024 and held it in 5 quarters. The position peaked at $34.6K in Q1 2024. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Allianz reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Allianz sold 35 Quest Diagnostics shares in Q2 2025, an estimated $5.92K.
  • Allianz first reported a position in Quest Diagnostics in Q1 2024 and held it in 5 quarters.
  • Allianz's Quest Diagnostics position peaked at $34.6K in Q1 2024.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Allianz's 13F filing for Q2 2025, filed 8 Aug 2025.